Plaqenil Role in Prevention of Age Related Macular Degeneration

Observational Study Between People That Use Plaquenil and Those Who do Not in Prevention of AMD.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01541449

Enrollment

Registered

2012-03-01

Start date

2012-01-31

Completion date

2012-04-30

Last updated

2012-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Related Macular Degeneration

Keywords

AMD, PLAQUENIL, CNV

Brief summary

The investigators think that there is a connection between the use of plaquenil and the prevention of Age related macular degeneration (AMD). The investigators believe that the use of plaquenil makes bruch's membrane thicker, thereby preventing Chroidal Neovascularization (CNV) growth.

Detailed description

the study is done by comparing to groups RA patients who take plaquenil Vs. group of patients who do not take plaquenil. after measuring the retina thickness we compare the avg. thickness of both groups.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* all people who suffer from rheumatoid arthritis (RA) and use plaquenil

Exclusion criteria

* patients who did not complete follow-up

Countries

Israel

Contacts

Primary ContactJoseph Pikkel, M.D

pikel.y@ziv.health.gov.il0508434206

Outcome results